Emotival

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Emotival

What is Emotival? Defining the Active Ingredient and Class

Property Description
Active ingredient Lorazepam
Form Tablet, Solution, Injection
Pharmacological class Benzodiazepine, CNS Depressant
General purpose Anxiolytic and Sedative-Hypnotic
Origin Synthetic Compound

Emotival is a distinct brand containing the active ingredient Lorazepam, a synthetic compound classified as a Benzodiazepine and a potent Central Nervous System (CNS) depressant. This medication is characterized by a rapid onset of action compared to some other long-acting agents in its class. The core chemical identity is Lorazepam, specifically identified by the structure 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one.


The classification of Emotival as a CNS depressant signifies that its overall purpose is to reduce or slow down activity in the central nervous system, providing a therapeutic benefit for individuals experiencing severe emotional distress or agitation. Lorazepam is used for its effect in treating such acute states, making it a choice when a reliable calming effect is necessary. The medication consistently functions as a single-ingredient product, containing only Lorazepam as the active component.


Forms, Composition, and General Purpose

Emotival is available in several official dosage forms, including the common tablet, an oral solution/concentrate, a sublingual tablet, and an injection (parenteral solution). These distinct preparations allow the Lorazepam component to be administered via various route of administration, including oral and intravenous or intramuscular injection in urgent care settings.


The drug's formulation utilizes the active Lorazepam component alongside various inactive substances (excipients) tailored for each delivery method. Lorazepam is classified as an essential medicine with an established sedative-hypnotic action. This pharmacological function, which involves enhancing the effects of the inhibitory neurotransmitter GABA, offers the general therapeutic benefit of reducing excitability, particularly in the brain's limbic and subcortical areas.

Regulatory References

  1. [NIH MedlinePlus](https://medlineplus.gov/druginfo/meds/a684004.html)
  2. Lorazepam in WHO Essential Medicines List

What side effects are possible with Emotival?

Possible Side Effects and Safety Information

The safety profile of Emotival (Lorazepam) is defined by its action as a Central Nervous System (CNS) depressant, resulting in a number of officially documented adverse reactions classified by frequency and body system.

Frequency-Classified Adverse Reactions

The most frequently documented effects relate to CNS function and are often more pronounced at the start of treatment or following a dose increase.

Classification Examples of Documented Effects
Very Common Sedation, somnolence (drowsiness)
Common Ataxia (unsteadiness), confusion, dizziness, fatigue, muscle weakness
Uncommon Nausea, constipation, changes in libido, skin reactions

Serious Adverse Reactions and Safety Constraints

Official regulatory documents emphasize the risk of serious adverse reactions, notably Respiratory Depression, Coma, and Death, especially when the medication is combined with other CNS depressants, such as opioids. A significant concern is the risk of physical and psychological dependence; this risk increases with the duration and dose of treatment and can lead to severe withdrawal syndromes upon cessation.

Safety limitations include absolute contraindications, such as known hypersensitivity to benzodiazepines and acute narrow-angle glaucoma. Furthermore, older adults may be more susceptible to CNS-related adverse effects like sedation and unsteadiness, increasing the documented risk of falls. Periodic monitoring (e.g., blood counts and liver-function tests) is recommended during long-term therapy.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Emotival (Lorazepam) is officially documented in regulatory sources as causing a continuum of Central Nervous System (CNS) depression. Initial documented manifestations include symptoms such as drowsiness, somnolence, confusion, ataxia (loss of coordination), and slurred speech.

The official prescribing information identifies specific severe and potentially life-threatening outcomes, including progression to stupor or coma. The most critical physiological risks documented are severe respiratory depression and profound hypotension (low blood pressure), which carry the risk of death, particularly if the medicine is co-ingested with other CNS depressants. Immediate medical attention is required upon suspicion of an overdose.

Regulatory guidelines explicitly state that emergency services must be contacted if the affected individual is unresponsive, exhibits severely slowed breathing, or has collapsed.

Management procedures are defined as supportive care alongside mandatory close hospital observation to monitor vital functions. While the benzodiazepine antagonist Flumazenil is documented as a possible intervention, its use carries an official warning regarding the risk of precipitating acute seizures in patients with physical dependence. Overdose considerations are also noted for specific populations, including heightened susceptibility in elderly or debilitated patients and documented risk of neonatal sedation.

Therapeutic Uses of Emotival

Emotival (Lorazepam) is used to provide symptomatic support across several therapeutic domains characterized by symptoms related to increased neurological or muscular activity and patient distress. The medication is used to help with anxiety and treat anxiety-related insomnia, alongside other relevant clinical applications.

What Emotival Treats: Main Uses and Benefits

The medication is indicated for the management of conditions presenting with acute episodes and heightened symptoms, which commonly include anxiety disorders, convulsive status epilepticus (continuous seizures), severe acute agitation, and alcohol withdrawal syndrome. It is applied across domains where short-term symptom management is appropriate, such as during phases of increased distress or before medical procedures.

“The medication provides supportive relief when symptoms interfere with routine activities.”

Symptomatic Relief for Acute Anxiety and Tension

This domain covers the use in situations involving severe tension, excessive worry, and panic disorder, where psychological symptoms cluster into patterns requiring supportive management. The medication is used to provide symptomatic relief that assists patients with symptom fluctuations, especially for the short-term management of acute anxiety.

Stabilization in Acute Crises

Emotival is relevant for addressing symptoms associated with acute or disruptive episodes, such as the emergency management of continuous seizures and severe acute agitation. In these acute situations, the medication supports the maintenance of functional stability and symptom stabilization.

Quick Fact: Relief for Severe Agitation The medication is relevant when symptoms become temporarily overwhelming, supporting short-term symptom stabilization during acute behavioral crises.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Emotival (Lorazepam) eligibility is strictly defined by official regulatory documentation, outlining populations for whom use is permitted, restricted, or absolutely prohibited. The adult population is generally approved for use, but specific medical conditions and age groups are subject to strict regulatory constraints.

Contraindications (Must Not Use)

Emotival is contraindicated in patients with a known hypersensitivity to benzodiazepines or formulation components. Use is also prohibited for individuals with myasthenia gravis, acute narrow-angle glaucoma, and severe conditions affecting organ function, such as severe hepatic insufficiency or acute pulmonary insufficiency/sleep apnea syndrome.

Age and Condition Restrictions

The regulatory label imposes strict age rules. The safety and efficacy for the oral tablet are not established in children younger than 12 years and are often outright contraindicated below the age of 6. For elderly and debilitated patients, the label mandates a substantial reduction of approximately 50% in the initial daily dosage.

Conditional Use and Non-Recommended Groups

Emotival is not recommended for use in women who are pregnant (FDA Category D) or lactating. It is also not recommended for use alone in patients with a primary depressive disorder or psychosis. Use requires caution in patients with a history of alcohol or drug abuse, and those with impaired renal function or compromised respiratory function.

What should I know about interactions with other medicines?

Interactions with other medicines and products — official regulatory information for Emotival

The interaction profile of Emotival (Lorazepam) is defined by its potential for profound additive Central Nervous System (CNS) effects and its unique, non-CYP-mediated metabolism.

Interaction Scope
Medicinal product categories with documented interactions: Opioids, other CNS Depressants (e.g., barbiturates, antipsychotics), Anticonvulsants (Valproate), Uricosurics (Probenecid), and Alcohol.
Mechanistic basis of interactions (only if stated in label): Pharmacodynamic (PD) enhancement resulting in additive sedation and respiratory depression; Pharmacokinetic (PK) inhibition of lorazepam’s glucuronidation, reducing clearance.
Interaction-related restrictions: Co-administration with Opioids is a serious risk that may lead to profound sedation, respiratory depression, coma, and death, documented by regulatory Boxed Warnings. The restriction requires reserving co-prescribing only when alternative treatments are inadequate.

Official interaction statements:

  • Opioids: Concomitant use with opioids carries the highest level of regulatory caution due to the risk of severe, life-threatening outcomes.
  • CNS Depressants and Alcohol: Concurrent administration with other CNS depressants, including Alcohol, leads to amplified CNS-depressant effects and increased potential for fatal respiratory depression.
  • Valproate and Probenecid: These agents are officially documented to increase the plasma concentration and prolong the half-life of lorazepam by inhibiting its glucuronidation pathway, requiring dosage consideration.

Population-specific interaction notes:

  • Neonates: Total clearance following intravenous administration is officially reduced, and the terminal half-life is prolonged, a pharmacokinetic difference noted in regulatory labeling.
  • Severe Hepatic Insufficiency: Use requires caution as lorazepam may officially worsen hepatic encephalopathy.

Mechanism of Action

How Emotival Works: Mechanism of Action

Emotival exerts its pharmacodynamic action through a dual mechanism primarily focused on modulating monoamine signaling within the central nervous system.

Targeting Dopamine Reuptake

Its function involves acting as an inhibitor of the Dopamine Transporter (DAT). This action prevents the reuptake of dopamine from the synaptic cleft, thereby elevating the neurotransmitter's concentration in the extraneuronal space, particularly within the mesolimbic pathway. The resulting sustained stimulation of postsynaptic receptors contributes to the modulation of reward processing and motivated behavior.

Modulating Serotonin Receptors

Simultaneously, Emotival acts as a modulator of the Serotonin System, engaging specific 5-HT receptor subtypes. For instance, it may function as an agonist at 5-HT1A receptors and an antagonist at 5-HT2C receptors. This direct receptor-level modulation affects signaling dynamics in the limbic system, leading to altered neuronal firing rates and signal transduction within those structures.

Dual Mechanism

This coordinated influence results in the simultaneous modulation of both monoamine reuptake and receptor-mediated signaling across interconnected central nervous system networks.

Dosage and Administration Information

How Emotival is Used: Administration Guidelines

Emotival, which contains the active ingredient Lorazepam, is used according to strict, short-term administration protocols. Administration typically covers the route, dosing, preparation, and duration.


Standard Routes and Preparation

Route of Administration Standard Dosing Frequency Preparation/Constraint Rule
Oral (Tablet, ER Capsule) Divided daily doses or a single dose at bedtime (insomnia). Tablets may be taken with or without food. Extended-release capsules must be swallowed whole and not crushed.
Oral Concentrate Divided daily doses. Must be diluted immediately before use in liquid or semi-solid food (e.g., water, juice, applesauce).
Intravenous (IV) / Intramuscular (IM) Single dose or limited repeated doses for acute use. IV injection must be diluted 1:1 with a compatible solution (e.g., Normal Saline) immediately before administration at a rate not exceeding 2 mg/minute.

Labeled Dosing and Duration

Dosage ranges differ by use. For adult anxiety management, the usual oral range is 2 mg to 6 mg per day in divided doses, typically starting at 2 mg to 3 mg daily. The dose is adjusted for specific populations; for older or debilitated adults, the initial daily oral dose is reduced to 1 mg to 2 mg in divided doses.

Use is generally restricted to short periods as efficacy has not been systematically assessed for continuous use beyond four months. Upon discontinuation after extended use, a gradual dosage-tapering schedule is recommended to manage the cessation process.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Emotival (Lorazepam)


Evidence for Use in Acute Seizure Management

Research into the use of Emotival for status epilepticus (continuous seizures) primarily used Randomized Controlled Trials (RCTs) and systematic reviews. These studies were conducted in emergency settings, often comparing Emotival with other medications in its class. The evidence is derived from research scenarios observing responses over defined time intervals, relevant in research exploring short-term symptom changes in conditions involving periods of heightened symptoms.

The outcomes that research examined included the time needed for seizure cessation, which was a primary endpoint, and measurements of the requirement for further medication. Findings describe patterns observed in these studies where research examined Emotival for use in these acute episodes. The evidence was assigned a High level based on consistency among studies exploring outcomes.


Evidence for Use in Acute Anxiety and Tension

Outcomes related to Emotival's use in the long-term, specifically beyond 4 months, have not been assessed by systematic clinical studies. The evidence base for using the oral form of Emotival to assess symptom patterns of anxiety disorders and acute tension is built largely on short-term, placebo-controlled trials.

Outcomes were typically evaluated by measuring symptom intensity or variability using formal anxiety rating scales. This research provides insight into short-term changes and is classified as contributing a Moderate to High level of evidence in research examining these conditions.

A key research limitation is that follow-up durations were limited, leaving the long-term effects of this use not fully established.


Evidence for Use in Acute Agitation and Withdrawal

Emotival was studied for the monitoring of symptom patterns associated with alcohol withdrawal syndrome (AWS) in comparative RCTs. Research examined endpoints related to severe complications like withdrawal seizures and monitored symptoms until defined clinical endpoints were reached.

Research exploring the use for severe acute agitation generally employed Comparative RCTs. However, evidence is limited for the drug when used as a single agent (monotherapy) for acute agitation, as the majority of controlled trials explored combination regimens.

Key Studies & References

  1. Lorazepam Oral Tablet - NIH MedlinePlus Drug Information
  2. Lorazepam Injection - NIH MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Emotival (FAQ)

Q: What is Emotival actually used for in real life?

A: Official product information states that Emotival is indicated for the short-term relief and management of anxiety symptoms or anxiety disorders. The drug is also approved for use as a premedicant for anesthesia and for specific acute medical conditions.

Q: Is Emotival a type of antidepressant or something else?

A: Regulatory documents classify Emotival as a benzodiazepine and a Central Nervous System (CNS) depressant. This classification is distinct from antidepressants. While it may be used for anxiety associated with depression, its primary use is for anxiety and sedation.

Q: Can you take Emotival with coffee or energy drinks?

A: Official documents do not list specific interactions between Emotival and common foods or beverages. However, because the drug can cause sedation and drowsiness, caution is advised regarding CNS-stimulating substances like caffeine, as the drug may worsen sedation.

Q: Is there a generic version of Emotival available?

A: The active ingredient in Emotival is Lorazepam. Because Lorazepam is a known chemical compound, generic, non-branded versions of the active ingredient, Lorazepam, are available.

Q: What is the difference between Emotival and other common treatments?

A: Studies and official information indicate that Emotival is recognized for its reliable and rapid onset of action. For oral doses, the drug is rapidly absorbed, with peak blood concentrations typically occurring in about two hours, which is a property noted in its pharmacological profile.

Q: Are there any long-term side effects associated with Emotival use?

A: Official documentation states that the drug’s long-term use has not been systematically assessed beyond four months. Furthermore, continuous use increases the risk of developing physical and psychological dependence, which requires a gradual dosage-tapering schedule upon discontinuation to manage withdrawal symptoms.

Q: Why is Emotival sometimes prescribed instead of other drugs?

A: Regulatory information indicates Emotival is often chosen in acute settings because of its rapid onset of action. This characteristic supports its use for conditions that require a quick response, such as status epilepticus (continuous seizures).

Q: Is Emotival used for anything besides its main approved purpose?

A: According to official product information, Emotival is approved for several uses. These include the short-term relief of anxiety-associated insomnia, premedication before anesthesia to reduce anxiety and promote sedation, and the treatment of status epilepticus.

Q: Is it true that Emotival works better if you take it at night?

A: Official indications for Emotival include the management of insomnia (trouble sleeping) associated with anxiety. For this specific purpose, the drug may be prescribed as a single dose to be taken at bedtime.

Q: What types of allergic reactions are possible with Emotival?

A: Official product information states that serious allergic reactions (hypersensitivity) are possible. Documented signs can include hives, itching, swelling of the face, tongue, or throat, or trouble breathing.

Q: What is the mechanism of action of Emotival in simple terms?

A: Emotival is a benzodiazepine that works by enhancing the effects of a natural calming chemical in the brain called GABA. This action slows down activity in the central nervous system, leading to a reduction in excitability and promoting a calming effect.

Q: Can people with liver or kidney problems take Emotival?

A: Regulatory documents state that caution is required for patients with impaired renal (kidney) or hepatic (liver) function. Use is prohibited in individuals with severe hepatic insufficiency (severe liver failure) due to the risk of worsening a brain condition called encephalopathy.

Q: How quickly does Emotival usually start to work?

A: According to official pharmacological data, when Emotival is taken by mouth, the concentration of the drug in the blood typically reaches its highest level in about two hours. When administered by injection, the maximal serum concentration is reached more rapidly, within 15 to 30 minutes.

Q: Does Emotival cause weight gain, or is that just a rumor?

A: Weight gain is not listed in regulatory documents as a common or very common adverse reaction. However, some comprehensive side effect profiles list changes in appetite or weight, though the incidence of this effect is generally not established in official reporting.

Q: Is Emotival considered a controlled substance?

A: Yes, official government bodies classify Emotival (Lorazepam) as a Schedule IV controlled substance. This classification indicates that the drug has an accepted medical use but also carries a potential for abuse and physical dependence.

Q: Can I take ibuprofen or pain relievers while using Emotival?

A: The highest risk interactions documented are related to Central Nervous System (CNS) depressants like opioids. Non-opioid pain relievers such as ibuprofen are generally not listed as high-risk interactions. However, some specific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may decrease the rate at which the body excretes Lorazepam.

Q: Is Emotival safe to use if I have an underlying heart condition?

A: Official warnings state that Emotival should be administered with caution in patients for whom a drop in blood pressure could lead to cardiac (heart) or cerebral (brain) complications. Although low blood pressure (hypotension) is a rare adverse effect, this warning is particularly emphasized for elderly patients.

Q: Does Emotival change your personality?

A: Official regulatory labels warn of rare, unexpected (paradoxical) reactions to the drug. These reactions can include acute rage, aggression, irritability, or increased excitation, which have necessitated the drug’s discontinuation in documented cases.

Q: Do you need a special kind of prescription for Emotival?

A: Yes, because Emotival is legally classified as a Schedule IV controlled substance, it requires a specific type of prescription. The dispensing and refilling of the medication are subject to strict regulations by law.

Q: Is Emotival linked to hair loss?

A: While alopecia (hair loss or thinning) is included in some comprehensive side effect profiles, it is not categorized as a common or frequently occurring adverse reaction. Official documents often note the incidence of this effect is very rare or not established.

Q: Are there any restrictions on driving or operating machinery while on Emotival?

A: Yes, due to common side effects such as sedation, dizziness, and decreased alertness, official sources warn against driving or operating machinery. Individuals are advised to refrain from engaging in these activities until the effects of the medication on their body are known.

Q: What is the half-life of Emotival?

A: According to official clinical pharmacology data, the mean half-life of the active component, Lorazepam, in human plasma is about 12 hours. The half-life is the time it takes for the amount of drug in the body to be reduced by half.

Q: Are there documented cases of Emotival overdose?

A: Yes, regulatory information documents the symptoms that may occur in the event of an overdose. These signs include confusion, extreme tiredness, problems with coordination, and slowed breathing and heartbeat, potentially leading to loss of consciousness.

Q: What research is currently being done on Emotival?

A: Official registers of clinical trials confirm that research is currently ongoing. For example, studies are assessing the risk of serious adverse events when starting treatment with different doses in older adults, particularly those with reduced kidney function.

Q: How long does Emotival stay in your system after the last dose?

A: Official pharmacological data indicates that the mean half-life of the drug is about 12 hours. Because complete elimination requires several half-lives, and its major metabolite has an 18-hour half-life, the drug and its components require multiple half-lives for elimination and may be detectable for an extended period.

Q: Why do some users report a decrease in appetite with Emotival?

A: Loss of appetite is included in comprehensive lists of possible side effects for Emotival. However, official documents note that the incidence (how often this occurs) is not clearly established.

Q: Does Emotival interact with herbal supplements like St. John's Wort?

A: Regulatory interaction information indicates that St. John's Wort may interact with benzodiazepines such as Emotival. This interaction could potentially increase side effects like drowsiness and reduce the drug’s effectiveness.

Q: Are there any specific lifestyle changes recommended while taking Emotival?

A: Official patient safety information provides recommendations centered on avoiding activities that require mental alertness, such as driving or operating machinery. Official warnings advise against the consumption of alcohol while taking the medication.

Q: Does Emotival affect blood pressure?

A: Yes, regulatory safety information reports that the drug may cause small decreases in blood pressure. Hypotension (low blood pressure) is a documented adverse effect, though it is reported rarely.

How should Emotival be stored and disposed of?

The storage and disposal of Emotival (lorazepam) must adhere strictly to regulatory requirements to ensure stability and public safety.


Storage Conditions and Stability

Dosage Form Required Storage Environment Post-Opening Stability
Injection/Oral Solution Refrigerated (2 C to 8 C), Protected from Light; Do not freeze Oral Solution: Discard after 90 days
Tablets Controlled Room Temperature (20 C to 25 C), Protect from excessive moisture Not applicable

All forms must be stored in the original container, kept tightly closed, and remain out of the reach of children and pets.


Disposal Instructions

Disposal should prioritize drug take-back programs at designated collection sites. If a take-back program is unavailable, unused medicine may be disposed of in the household trash. This alternative method requires mixing the medicine with an undesirable substance, such as coffee grounds or dirt, and placing the mixture in a sealed bag before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Emotival found in:

A-Z Index: